Nanoparticles: Alternatives against drug-resistant pathogenic microbes

Molecules

Volumn 21, Issue 7, 2016, Pages

  Rudramurthy, Gudepalya Renukaiah ^a   Swamy, Mallappa Kumara ^b   Sinniah, Uma Rani ^b   Ghasemzadeh, Ali ^b  

^a East West College of Pharmacy   (India)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Antibiotics; Antimicrobial; Drug resistance; Medicine; Metal oxide; Mode of action; Nanoparticles; Pathogens; Silver; Synthesis

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; BIOMATERIAL; METAL NANOPARTICLE; NANOCOMPOSITE; NANOPARTICLE;

ANIMAL; ANTIBIOTIC RESISTANCE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; DRUG FORMULATION; HUMAN; NANOTECHNOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; ANTIVIRAL AGENTS; BIOCOMPATIBLE MATERIALS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, MICROBIAL; HUMANS; METAL NANOPARTICLES; NANOCOMPOSITES; NANOPARTICLES; NANOTECHNOLOGY;

EID: 84979231140     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21070836     Document Type: Review

References (262)

1. Von Nussbaum, F.; Brands, M.; Hinzen, B.; Weigand, S.; Habich, D. Antibacterial natural products in medicinal chemistry-Exodus or revival? Angew. Chem. Int. Ed. 2006, 45, 5072-5129. [CrossRef] [PubMed]
2. Coates, A.; Hu, Y.; Bax, R.; Page, C. The future challenges facing the development of new antimicrobial drugs. Nat. Rev. Drug. Discov. 2002, 1, 895-910. [CrossRef] [PubMed]
3. Lemke, T.L.; Williams, D.A. Foye's Principles of Medicinal Chemistry; Lippincott Williams and Wilkins: Baltimore, MD, USA, 2008.
4. Verheij, T.J. The antibiotic revolution should be more focused. Br. J. Gen. Pract. 2009, 59, 716-717. [CrossRef] [PubMed]
5. Davey, P.; Sneddon, J.; Nathwani, D. Overview of strategies for overcoming the challenge of antimicrobial resistance. Expert. Rev. Clin. Pharmacol. 2010, 3, 667-686. [CrossRef] [PubMed]
6. Awad, H.M.; Kamal, Y.E.S.; Aziz, R.; Sarmidi, M.R.; El-Enshasy, H.A. Antibiotics as microbial secondary metabolites: Production and application. J. Teknol. 2012, 59, 101-111.
7. Boman, H.G. Innate immunity and the normal micro flora. Immunol. Rev. 2000, 173, 5-16. [CrossRef] [PubMed]
8. Gallo, R.L.; Huttner, K.M. Antimicrobial Peptides: An Emerging Concept in Cutaneous Biology. J. Investig. Dermatol. 1998, 111, 739-743. [CrossRef] [PubMed]
9. Jenssen, H.; Hamill, P.; Hancock, R.E.W. Peptide Antimicrobial Agents. Clin. Microbiol. Rev. 2006, 19, 491-511. [CrossRef] [PubMed]
10. Pushpanathan, M.; Gunasekaran, P.; Rajendhran, J. Antimicrobial Peptides: Versatile Biological Properties. Int. J. Pept. 2013. [CrossRef] [PubMed]
11. Drlica, K.; Malik, M.; Kernsm, R.J.; Zhaom, X. Quinolone-mediated bacterial death. Antimicrob. Agents Chemother. 2008, 52, 385-392. [CrossRef] [PubMed]
12. Eko, K.E.; Forshey, B.M.; Carrel, M.; Schweizer, M.L.; Perencevich, E.N.; Smith, T.C. Molecular characterization of methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization and infection isolates in a Veterans Affairs hospital. Antimicrob. Resist. Infect. Control. 2015. [CrossRef] [PubMed]
13. Schmieder, R.; Edwards, R. Insights into antibiotic resistance through metagenomic approaches. Future Microbiol. 2012, 7, 73-89. [CrossRef] [PubMed]
14. Crumplin, G.C.; Odell, M. Development of resistance to ofloxacin. Drugs 1987, 34, 1-8. [CrossRef] [PubMed]
15. Martinez, J.L.; Baquero, F. Mutation frequencies and antibiotic resistance. Antimicrob. Agents Chemother. 2000, 44, 1771-1777. [CrossRef] [PubMed]
16. Palmer, K.L.; Kos, V.N.; Gilmore, M.S. Horizontal gene transfer and the genomics of enterococcal antibiotic resistance. Curr. Opin. Microbiol. 2010, 13, 632-639. [CrossRef] [PubMed]
17. Hegstad, K.; Mikalsen, T.; Coque, T.M.; Werner, G.; Sundsfjord, A. Mobile genetic elements and their contribution to the emergence of antimicrobial resistant Enterococcus faecalis and Enterococcus faecium. Clin. Microbiol. Infect. 2010, 16, 541-554. [CrossRef] [PubMed]
18. Sengupta, P.P.; Balumahendiran, M.; Suryanarayana, V.V.S.; Raghavendra, A.G.; Shome, B.R.; Ganjendragad, M.R.; Prabhudas, K. PCR-based diagnosis of surra-targeting VSG gene: Experimental studies in small laboratory rodents and buffalo. Vet. Parasitol. 2010, 171, 22-31. [CrossRef] [PubMed]
19. Rudramurthy, G.R.; Sengupta, P.P.; Balamurugan, V.; Prabhudas, K.; Rahman, H. PCR based diagnosis of trypanosomiasis exploring invariant surface glycoprotein (ISG) 75 gene. Vet. Parasitol. 2013, 193, 47-58. [CrossRef] [PubMed]
20. Shaheen, B.W.; Wang, C.; Johnson, C.M.; Kaltenboeck, B.; Boothe, D.M. Detection of fluoroquinolone resistance level in clinical canine and feline Escherichia coli pathogens using rapid real-time PCR assay. Vet. Microbiol. 2009, 139, 379-385. [CrossRef] [PubMed]
21. Volokhov, D.; Chizhikov, V.; Chumakov, K.; Rasooly, A. Microarray analysis of erythromycin resistance determinants. J. Appl. Microbiol. 2003, 95, 787-798. [CrossRef] [PubMed]
22. Zhu, L.X.; Zhang, Z.W.; Wang, C.; Yang, H.W.; Jiang, D.; Zhang, Q.; Mitchelson, K.; Cheng, J. Use of a DNA microarray for simultaneous detection of antibiotic resistance genes among staphylococcal clinical isolates. J. Clin. Microbiol. 2007, 45, 3514-3521. [CrossRef] [PubMed]
23. Allen, H.K.; Moe, L.A.; Rodbumrer, J.; Gaarder, A.; Handelsman, J. Functional metagenomics reveals diverse β-lactamases in a remote Alaskan soil. ISME J. 2009, 3, 243-251. [CrossRef] [PubMed]
24. Donato, J.J.; Moe, L.A.; Converse, B.J.; Smart, K.D.; Berklein, F.C.; McManus, P.S. Metagenomic analysis of apple orchard soil reveals antibiotic resistance genes encoding predicted bifunctional proteins. Appl. Environ. Microbiol. 2010, 76, 4396-4401. [CrossRef] [PubMed]
25. Mori, T.; Mizuta, S.; Suenaga, H.; Miyazaki, K. Metagenomic screening for bleomycin resistance genes. Appl. Environ. Microbiol. 2008, 74, 6803-6805. [CrossRef] [PubMed]
26. Laxminarayan, R.; Duse, A.; Wattal, C.; Zaidi, A.K.; Wertheim, H.F.; Sumpradit, N.; Vlieghe, E.; Hara, G.L.; Gould, I.M.; Goossens, H.; Greko, C. Antibiotic resistance-The need for global solutions. Lancet Infect. Dis. 2013, 13, 1057-1098. [CrossRef]
27. Akhtar, M.; Swamy, M.K.; Umar, A.; Sahli, A.; Abdullah, A. Biosynthesis and characterization of silver nanoparticles from methanol leaf extract of Cassia didymobotyra and assessment of their antioxidant and antibacterial activities. J. Nanosci. Nanotechnol. 2015, 15, 9818-9823. [CrossRef] [PubMed]
28. Wong, I.Y.; Bhatia, S.N.; Toner, M. Nanotechnology: Emerging tools for biology and medicine. Genes Dev. 2013, 27, 2397-2408. [CrossRef] [PubMed]
29. Jena, M.; Mishra, S.; Jena, S.; Mishra, S.S. Nanotechnology-future prospect in recent medicine: A review. Int. J. Basic Clin. Pharmacol. 2013, 2, 353-359. [CrossRef]
30. Fröhlich, E.; Salar-Behzadi, S. Toxicological assessment of inhaled nanoparticles: Role of in vivo, ex vivo, in vitro, and in silico studies. Int. J. Mol. Sci. 2014, 15, 4795-4822. [CrossRef] [PubMed]
31. Ravishankar Rai, V.; Jamuna Bai, A. Nanoparticles and their potential application as antimicrobials. In Science against Microbial Pathogen: Communicating Current Research and Technological Advances; Méndez-Vilas, A., Ed.; Formatex Research Center: Badajoz, Spain, 2011; Volume 2, pp. 197-209.
32. Hajipour, J.M.; Fromm, K.M.; Ashkarran, A.A.; de Aberasturi, D.J.; de Larramendi, I.R.; Rojo, T.; Serpooshan, V.; Parak, W.J.; Mahmoudi, M. Antibacterial properties of nanoparticles. Trend Biotechnol. 2012, 30, 499-511. [CrossRef] [PubMed]
33. Whitesides, G.M. Nanoscience, nanotechnology, and chemistry. Small 2005, 1, 172-179. [CrossRef] [PubMed]
34. Feynman, R. There's plenty of room at the bottom. Science 1991, 254, 1300-1301.
35. Adibkia, K.; Omidi, Y.; Siahi, M.R.; Javadzadeh, A.R.; Barzegar-Jalali, M.; Barar, J.; Maleki, N.; Mohammadi, G.; Nokhodchi, A. Inhibition of endotoxin-induced uveitis by methylprednisolone acetate nanosuspension in rabbits. J. Ocul. Pharmacol. Ther. 2007, 23, 421-432. [CrossRef] [PubMed]
36. Tiwari, P.M.; Vig, K.; Dennis, V.A.; Singh, S.R. Functionalized gold nanoparticles and their biomedical applications. Nanomaterials 2011, 1, 31-63. [CrossRef]
37. Zinjarde, S.S. Bio-inspired nanomaterials and their applications as antimicrobial agents. Chronic Young Sci. 2012, 3, 74-81. [CrossRef]
38. Bahrami, K.; Nazari, P.; Nabavi, M.; Golkar, M.; Almasirad, A.; Shahverdi, A.R. Hydroxyl capped silver-gold alloy nanoparticles: Characterization and their combination effect with different antibiotics against Staphylococcus aureus. Nanomed. J. 2014, 1, 155-161.
39. Dizaj, S.M.; Mennati, A.; Jafari, S.; Khezri, K.; Adibkia, K. Antimicrobial activity of carbon-based nanoparticles. Adv. Pharm. Bull. 2015, 5, 19-23.
40. Nam, J.M.; Thaxton, C.S.; Mirkin, C.A. Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science 2003, 301, 1884-1886. [CrossRef] [PubMed]
41. Chen, H.; Kou, X.; Yang, Z.; Ni, W.; Wang, J. Shape- and size-dependent refractive index sensitivity of gold nanoparticles. Langmuir 2008, 24, 5233-5237. [CrossRef] [PubMed]
42. Osterfeld, S.J.; Yub, H.; Gaster, R.S.; Caramuta, S.; Xu, L.; Han, S.J.; Hall, D.A.; Wilson, R.J.; Sun, S.; White, R.L.; et al. Multiplex protein assays based on real-time magnetic nanotag sensing. Proc. Natl. Acad. Sci. USA 2008, 105, 20637-20640. [CrossRef] [PubMed]
43. Prabhu, S.; Poulose, E.K. Silver nanoparticles: Mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects. Int. Nano Lett. 2012, 2. [CrossRef]
44. Swamy, M.K.; Akhtarc, M.S.; Mohantya, S.K.; Sinniah, U.R. Synthesis and characterization of silver nanoparticles using fruit extract of Momordica cymbalaria and assessment of their in vitro antimicrobial, antioxidant and cytotoxicity activities. Spec. Acta Part A Mol. Biomol. Spectr. 2015, 151, 939-944. doi:10.1016/j.saa.2015.07.009.
45. Haider, A.; Kang, I.K. Preparation of silver nanoparticles and their industrial and biomedical applications: A comprehensive review. Adv. Mater. Sci. Eng. 2015. [CrossRef]
46. Malik, P.; Shankar, R.; Malik, V.; Sharma, N.; Mukherjee, T.K. Green chemistry based benign routes for nanoparticle synthesis. J. Nanopar. 2014. [CrossRef]
47. Tanja, K.; Ralph, J.; Eva, O.; Claes-Göran, G. Silver-based crystalline nanoparticles, microbially fabricated. PNAS 1999, 96, 13611-13614.
48. Fu, J.K.; Zhang, W.D.; Liu, Y.Y.; Lin, Z.Y.; Yao, B.X.; Weng, S.Z.; Zeng, J.L. Characterization of adsorption and reduction of noble metal ions by bacteria. Chem. J. Chin. Univ. 1999, 20, 1452-1454.
49. El-Shanshoury, A.E.R.; ElSilk, S.E.; Ebeid, M.E. Extracellular biosynthesis of silver nanoparticles using Escherichia coli ATCC 8739, Bacillus subtilis ATCC 6633, and Streptococcus thermophilus ESh1 and their antimicrobial activities. ISRN Nanotechnol. 2011. [CrossRef]
50. Bhainsa, C.K.; D'Souza, F.S. Extracellular biosynthesis of silver nanoparticles using the fungus Aspergillus funigatus. Colloids Surf. B Biointerfaces 2006, 47, 160-164. [CrossRef] [PubMed]
51. Gade, A.; Ingle, A.; Bawaskar, M.; Rai, M. Fusarium solani: A novel biological agent for extracellular synthesis of nanoparticles. J. Nanopart. Res. 2009, 11, 2079-2085.
52. Chandran, S.P.; Chaudhary, M.; Pasricha, R.; Ahmad, A.; Sastry, M. Synthesis of gold nanotriangles and silver nanoparticles using Aloe vera plant extract. Biotechnol. Prog. 2006, 22, 577-583. [CrossRef] [PubMed]
53. Mallikarjuna, K.; Dillip, G.R.; Narasimha, G.; John Sushma, N.; Deva Prasad Raju, B. Phytofabrication and characterization of silver nanoparticles from Piper betle broth. Res. J. Nanosci. Nanotechnol. 2012, 2, 17-23.
54. Swamy, M.K.; Sudipta, K.M.; Jayanta, K.; Balasubramanya, S. The green synthesis, characterization, and evaluation of the biological activities of silver nanoparticles synthesized from Leptadenia reticulata leaf extract. Appl. Nanosci. 2015, 5, 73-81. [CrossRef]
55. Keat, C.L.; Aziz, A.; Eid, A.M.; Elmarzugi, N.A. Biosynthesis of nanoparticles and silver nanoparticles. Bioresour. Bioprocess. 2015, 2. [CrossRef]
56. Mashwani, Z.R.; Khan, T.; Khan, M.A.; Nadhman, A. Synthesis in plants and plant extracts of silver nanoparticles with potent antimicrobial properties: Current status and future prospects. Appl. Microbiol. Biotechnol. 2015, 99, 9923-9934. [CrossRef] [PubMed]
57. Franci, G.; Falanga, A.; Galdiero, S.; Palomba, L.; Rai, M.; Morelli, G.; Galdiero, M. Silver nanoparticles as potential antibacterial agents. Molecules 2015, 20, 8856-8874. [CrossRef] [PubMed]
58. Lemire, J.A.; Harrison, J.J.; Turner, R.J. Antimicrobial activity of metals: Mechanisms, molecular targets and applications. Nat. Rev. Microbiol. 2013, 11, 371-384. [CrossRef] [PubMed]
59. Reidy, B.; Haase, A.; Luch, A.; Dawson, K.A.; Lynch, I. Mechanisms of silver nanoparticle release, transformation and toxicity: A critical review of current knowledge and recommendations for future studies and applications. Materials 2013, 6, 2295-2350. [CrossRef]
60. Yamanaka, M.; Hara, K.; Kudo, J. Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis. Appl. Environ. Microbiol. 2005, 71, 7589-7593. [CrossRef] [PubMed]
61. Shahverdi, A.R.; Fakhimi, A.; Shahverdi, H.R.; Minaian, S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomed. Nanotechnol. Biol. Med. 2007, 3, 168-171. [CrossRef] [PubMed]
62. Sarkar, S.; Jana, A.D.; Samanta, S.K.; Mostafa, G. Facile synthesis of silver nanoparticles with highly efficient anti-microbial property. Polyhedron 2007, 26, 4419-4426. [CrossRef]
63. Shrivastava, S.; Bera, T.; Roy, A.; Singh, G. Ramachandra Rao P, Dash D. Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology 2007, 18. [CrossRef]
64. Ramalingam, B.; Parandhaman, T.; Das, S.K. Antibacterial effects of biosynthesized silver nanoparticles on surface ultrastructure and nanomechanical properties of Gram-negative bacteria viz. Escherichia coli and Pseudomonas aeruginosa. ACS Appl. Mater. Interfaces 2016, 8, 4963-4976. [CrossRef] [PubMed]
65. Morones, J.R.; Elechiguerra, J.L.; Camacho, A.; Holt, K.; Kouri, J.B.; Tapia, J.; Yacaman, M.J. The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16, 2346-2353. [CrossRef] [PubMed]
66. Krishnamoorthy, K.; Manivannan, G.; Kim, S.J.; Jeyasubramanian, K.; Premanathan, M. Antibacterial activity of MgO nanoparticles based on lipid peroxidation by oxygen vacancy. J. Nano Res. 2012, 14. [CrossRef]
67. Koper, O.; Klabunde, J.; Marchin, G.; Klabunde, K.J.; Stoimenov, P.; Bohra, L. Nanoscale powders and formulations with biocidal activity toward spores and vegetative cells of Bacillus species, viruses, and toxins. Curr. Microbiol. 2002, 44, 49-55. [CrossRef] [PubMed]
68. Hirakawa, K.; Mori, M.; Yoshida, M.; Oikawa, S.; Kawanishi, S. Photo-irradiated titanium dioxide catalyzes site specific DNA damage via generation of hydrogen peroxide. Free Radic. Res. 2004, 38, 439-447. [CrossRef] [PubMed]
69. Besinis, A.; de Peralta, T.; Handy, R.D. The antibacterial effects of silver, titanium dioxide and silica dioxide nanoparticles compared to the dental disinfectant chlorhexidine on Streptococcus mutans using a suite of bioassays. Nanotoxicology 2014, 8. [CrossRef] [PubMed]
70. Yamamoto, O. Influence of particle size on the antibacterial activity of zinc oxide. Int. J. Inorg. Mater. 2011, 3, 643-646. [CrossRef]
71. Padmavathy, N.; Vijayaraghavan, R. Enhanced bioactivity of ZnO nanoparticles-An antimicrobial study. Sci. Technol. Adv. Mater. 2008, 9. [CrossRef]
72. Brayner, R.; Ferrari-Iliou, R.; Brivois, N.; Djediat, S.; Benedetti, M.F.; Fiévet, F. Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. Nano Lett. 2006, 6, 866-870. [CrossRef] [PubMed]
73. Tayel, A.A.; El-Tras, W.F.; Moussa, S.; El-Baz, A.F.; Mahrous, H.; Salem, M.F.; Brimer, L. Antibacterial action of zinc oxide nanoparticles against foodborne pathogens. J. Food Saf. 2011, 31, 211-218. [CrossRef]
74. Liu, Y.; He, L.; Mustapha, A.; Li, H.; Hu, ZQ.; Lin, M. Antibacterial activities of zinc oxide nanoparticles against Escherichia coli O157:H7. J. Appl. Microbiol. 2009, 107, 1193-1201. [CrossRef] [PubMed]
75. Gil-Tomas, J. Lethal photosensitisation of Staphylococcus aureus using a toluidine blue O-tiopronin-gold nanoparticles conjugate. J. Mater. Chem. 2007, 17, 3739-3746. [CrossRef]
76. Pissuwan, D.; Cortie, C.H.; Valenzuela, S.M.; Cortie, M.B. Functionalised gold nanoparticles for controlling pathogenic bacteria. Trends Biotechnol. 2009, 28, 207-213. [CrossRef] [PubMed]
77. Perni, S. The antimicrobial properties of light-activated polymers containing methylene blue and gold nanoparticles. Biomaterials 2009, 30, 89-93. [CrossRef] [PubMed]
78. Rai, A.; Prabhune, A.; Perry, C.C. Antibiotic mediated synthesis of gold nanoparticles with potent antimicrobial activity and their application in antimicrobial coatings. J. Mater. Chem. 2010, 20, 6789-6798. [CrossRef]
79. Sampath, M.; Vijayan, R.; Tamilarasu, E.; Tamilselvan, A.; Sengottuvelan, B. Green synthesis of novel jasmine bud-shaped copper nanoparticles. J. Nanotechnol. 2014, 2014. [CrossRef]
80. Chatterjee, A.K.; Sarkar, R.K.; Chattopadhyay, A.P.; Aich, P.; Chakraborty, R.; Basu, T. A simple robust method for synthesis of metallic copper nanoparticles of high antibacterial potency against E. coli. Nanotechnology 2012, 23, 85-103. [CrossRef] [PubMed]
81. Raffi, M.; Mehrwan, S.; Bhatti, T.M.; Akhter, J.I.; Hameed, A.; Yawar, W.; ulHasan, M.M. Investigations into the antibacterial behavior of copper nanoparticles against Escherichia coli. Ann. Microbiol. 2010, 60, 75-80. [CrossRef]
82. Rupareli, J.P.; Chatterjee, A.K.; Duttagupta, S.P.; Mukherji, S. Strain specificity in antimicrobial activity of silver and copper nanoparticles. Acta Biomater. 2008, 4, 707-771. [CrossRef] [PubMed]
83. Behera, S.S.; Patra1, J.K.; Pramanik, K.; Panda, N.; Thatoi, H. Characterization and Evaluation of antibacterial activities of chemically synthesized Iron Oxide nanoparticles. World J. Nano Sci. Eng. 2012, 2, 196-200. [CrossRef]
84. Sadiq, M.; Chowdhury, B.; Chandrasekaran, N.; Mukherjee, A. Antimicrobial sensitivity of Escherichia coli to alumina nanoparticles. Nanomed. Nanotechnol. Biol. Med. 2009, 5, 282-286. [CrossRef] [PubMed]
85. Luo, Y.; Hossain, M.; Wang, C.; Qiao, Y.; An, J.; Ma, L.; Su, M. Targeted nanoparticles for enhanced X-ray radiation killing of multi drug resistant bacteria. Nanoscale 2013, 5, 687-694. [CrossRef] [PubMed]
86. Nazari, P.; Dowlatabadi-Bazaz, R.; Mofid, M.R.; Pourmand, M.R.; Daryani, N.E.; Faramarzi, M.A.; Sepehrizadeh, Z.; Shahverdi, A.R. The Antimicrobial effects and metabolomic footprinting of carboxyl-capped bismuth nanoparticles against Helicobacter pylori. Appl. Biochem. Biotechnol. 2013, 172, 570-579. [CrossRef] [PubMed]
87. Yang, S.; Herzberg, M.; Rodrigues, D.F.; Elimelech, M. Antibacterial effects of carbon nanotubes: Size does matter. Langmuir 2008, 24, 6409-6013.
88. Yang, C.; Mamouni, J.; Tang, Y.; Yang, L. Antimicrobial activity of single-walled carbon nanotubes: Length effect. Langmuir 2010, 26, 6013-6019. [CrossRef] [PubMed]
89. Shvedova, A.A.; Pietroiusti, A.; Fadeel, B.; Kagan, V.E. Mechanisms of carbon nanotube-induced toxicity: Focus on oxidative stress. Toxicol. Appl. Pharmacol. 2012, 261, 121-133. [CrossRef] [PubMed]
90. Dong, L.; Henderson, A.; Field, C. Antimicrobial activity of single-walled carbon nanotubes suspended in different surfactants. J. Nanotechnol. 2012, 2012. [CrossRef]
91. Leid, J.; Ditto, A.; Knapp, A.; Shah, P.; Wright, B.; Blust, R.; Christensen, L.; Clemons, C.B.; Wilber, J.P.; Young, G.W.; et al. In vitro antimicrobial studies of silver carbine complexes: Activity of free and nanoparticle carbene formulations against clinical isolates of pathogenic bacteria. J. Antimicrob. Chemother. 2012, 67, 138-148. [CrossRef] [PubMed]
92. Fu, P.P.; Xia, Q.; Hwang, H.M.; Ray, P.C.; Yu, H. Mechanisms of nanotoxicity: Generation of reactive oxygen species. J. Food Drug Anal. 2014, 22, 64-75. [CrossRef] [PubMed]
93. Lara, H.H.; Ayala-Núnez, N.V.; Turrent, L.D.C.I.; Padilla, C.R. Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria. World J. Microbiol. Biotechnol. 2010, 26, 615-621. [CrossRef]
94. Pérez-Díaz, M.A.; Boegli, L.; James, G.; Velasquillo, C.; Sánchez-Sánchez, R.; Martínez-Martínez, R.E.; Martínez-Castañón, G.A.; Martinez-Gutierrez, F. Silver nanoparticles with antimicrobial activities against Streptococcus mutans and their cytotoxic effect. Mater. Sci. Eng. C Mater. Biol. Appl. 2015, 55, 360-366. [CrossRef] [PubMed]
95. Pereira, L.; Dias, N.; Carvalho, J.; Fernandes, S.; Santos, C.; Lima, N. Synthesis, characterization and antifungal activity of chemically and fungal-produced silver nanoparticles against Trichophyton rubrum. J. Appl. Microbiol. 2014, 117, 1601-1613. [CrossRef] [PubMed]
96. Mallmann, E.J.J.; Cunha, F.A.; Castro, B.N.; Maciel, A.M.; Menezes, E.A.; Fechine, P.B.A. Antifungal activity of silver nanoparticles obtained by green synthesis. Rev. Inst. Med. Trop. Sao. Paul. 2015, 57, 165-167. [CrossRef] [PubMed]
97. Ogar, A.; Tylko, G.; Turnau, K. Antifungal properties of silver nanoparticles against indoor mould growth. Sci. Total Environ. 2015, 521, 305-314. [CrossRef] [PubMed]
98. Panáček, A.; Kolář, M.; Večeřová, R.; Prucek, R.; Soukupová, J.; Kryštof, V.; Hamal, P.; Zbořil, R.; Kvítek, L. Antifungal activity of silver nanoparticles against Candida spp. Biomaterials 2009, 30, 6333-6340. [CrossRef] [PubMed]
99. Sundrarajan, M.; Suresh, J.; Gandhi, R.R. A comparative study on antibacterial properties of MgO nanoparticles prepared under different calcinations temperature. Dig. J. Nanomater. Biostruct. 2012, 7, 983-989.
100. Fang, M.; Chen, J.H.; Xu, X.L.; Yang, P.H.; Hildebrand, H.F. Antibacterial activities of inorganic agents on six bacteria associated with oral infections by two susceptibility tests. Int. J. Antimicrob. Agents 2006, 27, 513-517. [CrossRef] [PubMed]
101. Jones, N.; Ray, B.; Koodali, R.T.; Manna, A.C. Antibacterial activity of ZnO nanoparticles suspensions on a broad spectrum of microorganisms. FEMS Microbiol. Lett. 2008, 279, 71-76. [CrossRef] [PubMed]
102. Manna, A.C. Synthesis, Characterization, and Antimicrobial Activity of Zinc Oxide Nanoparticles. In Nano-Antimicrobials: Progress and Prospects; Cioffi, N., Rai, M., Eds.; Springer Science & Business Media: Berlin/Heidelberg, Germany, 2012; pp. 151-180.
103. Tang, Z.X.; Feng, B. MgO nanoparticles as antibacterial agent: Preparation and activity. Braz. J. Chem. Eng. 2014, 31, 591-601. [CrossRef]
104. Kumar, A.; Kumar, J. On the synthesis and optical absorption studies of nano-size magnesium oxide powder. J. Phys. Chem. Sol. 2008, 69, 2764-2772. [CrossRef]
105. Selvam, N.C.S.; Kumar, R.T.; Kennedy, L.J.; Vijaya, J.J. Comparative study of microwave and conventional methods for the preparation and optical properties of novel MgO-micro and nanostructures. J. Alloy Comp. 2011, 509, 9809-9815. [CrossRef]
106. Jin, T.; He, Y. Antibacterial activities of magnesium oxide (MgO) nanoparticles against foodborne pathogens. J. Nanopart. Res. 2011, 13, 6877-6885. [CrossRef]
107. Huang, L.; Li, D.Q.; Lin, Y.J.; Wei, M.; Evans, D.G.; Duan, X. Controllable preparation of Nano-MgO and investigation of its bactericidal properties. J. Inorg. Biochem. 2005, 99, 986-993. [CrossRef] [PubMed]
108. Richards, R.; Li, W.; Decker, S.; Davidson, C.; Koper, O.; Zaikovski, V.; Volodin, A.; Rieker, T.; Klabunde, K. Consolidation of metal oxide nanocrystals. Reactive pellets with controllable pore structure that represent a new family of porous, inorganic materials. J. Am. Chem. Soc. 2000, 122, 4921-4925. [CrossRef]
109. Zeng, H.C. Preparation and integration of nanostructured titanium dioxide. Curr. Opin. Chem. Eng. 2011, 1, 11-17. [CrossRef]
110. Trouiller, B.; Reliene, R.; Westbrook, A.; Solaimani, P.; Schiest, R.H. Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in mice. Cancer Res. 2009, 69, 8784-8789. [CrossRef] [PubMed]
111. Allahverdiyev, A.M.; Abamor, E.S.; Bagirova, M.; Rafailovich, M. Antimicrobial effects of TiO(2) and Ag(2)O nanoparticles against drug-resistant bacteria and leishmania parasites. Future Microbiol. 2011, 8, 933-940. [CrossRef] [PubMed]
112. Li, Y.F.; Liu, Z.P.; Liu, L.; Gao, W. Mechanism and activity of photocatalytic oxygen evolution on titania anatase in aqueous surroundings. J. Am. Chem. Soc. 2010, 132, 13008-13015. [CrossRef] [PubMed]
113. Wong, M.S.; Chu, W.C.; Sun, D.S.; Huang, H.S.; Chen, J.H.; Tsai, P.J.; Lin, N.T.; Yu, M.S.; Hsu, S.F.; Wang, S.L.; Chang, H.H. Visible-light-induced bactericidal activity of a nitrogen-doped titanium photocatalyst against human pathogens. Appl. Environ. Microbiol. 2006, 72, 6111-6116. [CrossRef] [PubMed]
114. Wu, P.; Xie, R.; Imlay, K.; Shang, J.K. Visible-light-induced bactericidal activity of titanium dioxide codoped with nitrogen and silver. Environ. Sci. Technol. 2010, 44, 6992-6997. [CrossRef] [PubMed]
115. 2 and ozone on the resistant Aspergillus niger spore. J. Hazard. Mater. 2013, 261, 155-162. [CrossRef] [PubMed]
116. Xie, Y.; He, Y.; Irwin, P.L.; Jin, T.; Shi, X. Antibacterial activity and mechanism of action of zinc oxide nanoparticles against Campylobacter jejuni. Appl. Environ. Microbiol. 2011, 77, 2325-2331. [CrossRef] [PubMed]
117. Vidic, J.; Stankic, S.; Haque, F.; Ciric, D.; Le Goffic, R.; Vidy, A.; Jupille, J.; Delmas, B. Selective antibacterial effects of mixed ZnMgO nanoparticles. J. Nanopart. Res. 2013, 15, 1-10. [CrossRef] [PubMed]
118. Reddy, K.M.; Feris, K.; Bell, J.; Wingett, D.G.; Hanley, C.; Punnoose, A. Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systems. Appl. Phys. Lett. 2007, 90. [CrossRef] [PubMed]
119. Nair, S.; Sasidharan, A.; Rani, V.D.; Menon, D.; Nair, S.; Manzoor, K.; Raina, S. Role of size scale of ZnO nanoparticles and microparticles on toxicity toward bacteria and osteoblast cancer cells. J. Mater. Sci. Mater. Med. 2009, 20, 235-241. [CrossRef] [PubMed]
120. Li, M.; Zhu, L.; Lin, D. Toxicity of ZnO nanoparticles to Escherichia coli: Mechanism and the influence of medium components. Environ. Sci. Technol. 2011, 45, 1977-1983. [CrossRef] [PubMed]
121. Pati, R.; Mehta, R.K.; Mohanty, S.; Padhi, A.; Sengupta, M.; Vaseeharan, B.; Goswami, C.; Sonawane, A. Topical application of zinc oxide nanoparticles reduces bacterial skin infection in mice and exhibits antibacterial activity by inducing oxidative stress response and cell membrane disintegration in macrophages. Nanomed. Nanotech. Biol. Med. 2014, 10, 1195-1208. [CrossRef] [PubMed]
122. Stoimenov, P.K.; Klinger, R.L.; Marchin, G.L.; Klabunde, K.J. Metal oxide nanoparticles as bactericidal agents. Langmuir 2002, 18, 6679-6686. [CrossRef]
123. 2 core/shell magnetic nanoparticles as photokilling agents for pathogenic bacteria. Small 2008, 4, 485-491. [CrossRef] [PubMed]
124. Tran, N.; Mir, A.; Mallik, D.; Sinha, A.; Nayar, S.; Webster, T.J. Bactericidal effect of iron oxide nanoparticles on Staphylococcus aureus. Int. J. Nanomed. 2010, 5, 277-283.
125. 4 nanoparticles and its antibacterial application. Int. Nano Lett. 2015, 5, 85-92. [CrossRef]
126. Lee, C.; Kim, J.Y.; Lee, W.I.; Nelson, K.L.; Yoon, J.; Sedlak, D.L. Bactericidal effect of zero-valent iron nanoparticles on Escherichia coli. Environ. Technol. 2008, 42, 4927-4933. [CrossRef]
127. Taylor, E.N.; Webster, T.J. The use of superparamagnetic nanoparticles for prosthetic biofilm prevention. Int. J. Nanomed. 2009, 4, 145-152.
128. Arokiyaraj, S.; Saravanan, M.; Prakash, N.U.; Arasu, M.V.; Vijayakumar, B.; Vincent, S. Enhanced antibacterial activity of iron oxide magnetic nanoparticles treated with Argemone mexicana L. leaf extract: An in vitro study. Mater. Res. Bull. 2013, 8, 3323-3327. [CrossRef]
129. Anghel, I.; Grumezescu, A.M.; Andronescu, E.; Anghel, A.G.; Ficai, A.; Saviuc, C.; Grumezescu, V.; Vasile, B.S.; Chifiriuc, M.C. Magnetite nanoparticles for functionalized textile dressing to prevent fungal biofilms development. Nanoscale Res. Lett. 2012, 7. [CrossRef] [PubMed]
130. Chifiriuc, C.; Grumezescu, V.; Grumezescu, A.M.; Saviuc, C.; LazǍr, V.; Andronescu, E. Hybrid magnetite nanoparticles/Rosmarinus officinalis essential oil nanobiosystem with antibiofilm activity. Nanoscale Res. Lett. 2012, 7. [CrossRef] [PubMed]
131. Boisselier, E.; Astruc, D. Gold nanoparticles in nanomedicine: Preparations, imaging, diagnostics, therapies and toxicity. Chem. Soc. Rev. 2009, 38, 1759-1782. [CrossRef] [PubMed]
132. Daniel, M.-C.; Astruc, D. Gold nanoparticles: Assembly, Supramolecular Chemistry, Quantum-size Related Properties, and Applications towards Biology, Catalysis and Nanotechnology. Chem. Rev. 2004, 104, 293-346. [CrossRef] [PubMed]
133. Sanvicens, N.; Marco, M.P. Multifunctional nanoparticles-Properties and prospects for their use in human medicine. Trends Biotechnol. 2008, 26, 425-433. [CrossRef] [PubMed]
134. Li, N.; Zhao, P.; Astruc, D. Anisotropic Gold Nanoparticles: Synthesis, Properties, Applications, and Toxicity. Angew. Chem. Int. Ed. 2014, 53, 1756-1789. [CrossRef] [PubMed]
135. Patra, C.R.; Bhattacharya, R.; Mukhopadhyay, D.; Mukherjee, P. Fabrication of Gold Nanoparticles for targeted therapy in pancreatic cancer. Adv. Drug Deliv. Rev. 2009, 62, 346-361. [CrossRef] [PubMed]
136. Radwan, S.H.; Azzay, H.M. Gold nanoparticles for molecular diagnosis. Expert Rev. Mol. Diagn. 2009, 9, 511-524. [CrossRef] [PubMed]
137. Rasch, M.R.; Konstantin, V.; Brian, A. Limitations on the optical tunability of small diameter Gold nanoshells. Langmuir 2009, 25, 11777-11785. [CrossRef] [PubMed]
138. Alex, S.; Tiwari, A. Functionalized gold nanoparticles: Synthesis, properties and applications-A review. J. Nanosci. Nanotechnol. 2015, 15, 1869-1894. [CrossRef] [PubMed]
139. Nikoobakht, B.; El-Sayed, M.A. Preparation and growth mechanism of Gold nanorods (NRs) using seed-nediated growth method. Chem. Mater. 2003, 15, 1957-1962. [CrossRef]
140. He, S.; Guo, Z.; Zhang, Y.; Zhang, S.; Wang, J.; Gu, N. Biosynthesis of gold nanoparticles using the bacteria Rhodopseudomonas capsulata. Mater. Lett. 2007, 61, 3984-3987. [CrossRef]
141. Badri Narayanan, K.; Sakthivel, N. Coriander leaf mediated biosynthesis of gold nanoparticles. Mater. Lett. 2008, 62, 4588-4590. [CrossRef]
142. Kasthuri, J.; Veerapandian, S.; Rajendiran, N. Biological synthesis of silver and gold nanoparticles using apiin as reducing agent. Colloids Surf. B 2009, 68, 55-60. [CrossRef] [PubMed]
143. Chauhan, A.; Zubair, S.; Tufail, S.; Sherwani, A.; Sajid, M.; Raman, S.C.; Azam, A.; Owais, M. Fungus-mediated biological synthesis of gold nanoparticles: Potential in detection of liver cancer. Int. J. Nanomed. 2011, 6, 2305-2319.
144. Bapista, P.; Periera, E.; Eaton, P.; Doria, G.; Miranda, A.; Gomes, I.; Quaresma, P.; Franco, R. Gold nanoparticles for the development of clinical diagnosis methods. Ann. Bioannal. Chem. 2008, 391, 943-950. [CrossRef] [PubMed]
145. Zharov, V.P. Photothermal nanotherapeutics and nanodiagnostics for selective killing of bacteria targeted with gold nanoparticles. Biophys. J. 2006, 90, 619-627. [CrossRef] [PubMed]
146. Gu, H.; Ho, P.L.; Tong, E.; Wang, L.; Xu, B. Presenting vancomycin on nanoparticles to enhance antimicrobial activities. Nano Lett. 2003, 3, 1261-1263. [CrossRef]
147. Burygin, G.L. On the enhanced antibacterial activity of antibiotics mixed with gold nanoparticles. Nanoscale Res. Lett. 2009, 4, 794-801. [CrossRef] [PubMed]
148. Grace, N.A.; Pandian, K. Antibacterial efficacy of aminoglycosidic antibiotics protected gold nanoparticles-A brief study. Colloids Surf. A Physicochem. Eng. Asp. 2007, 297, 63-70. [CrossRef]
149. Saha, B. In vitro structural and functional evaluation of gold nanoparticles conjugated antibiotics. Nanoscale Res. Lett. 2007, 2, 614-622. [CrossRef]
150. Khan, S.; Alam, F.; Azam, A.; Khan, A.U. Gold nanoparticles enhance methylene blue-induced photodynamic therapy: A novel therapeutic approach to inhibit Candida albicans biofilm. Int. J. Nanomed. 2012, 7, 3245-3257. [CrossRef] [PubMed]
151. Li, X.; Robinson, S.M.; Gupta, A.; Saha, K.; Jiang, Z.; Moyano, D.F.; Sahar, A.; Riley, M.A.; Rotello, V.M. Functional gold nanoparticles as potent antimicrobial agents against multi-drug-resistant bacteria. ACS Nano 2014, 8, 10682-10686. [CrossRef] [PubMed]
152. Bresee, J.; Maier, K.E.; Boncella, A.E.; Melander, C.; Feldheim, D.L. Growth inhibition of Staphylococcus aureus by mixed monolayer gold nanoparticles. Small 2011, 7, 2027-2031. [CrossRef] [PubMed]
153. Fayaz, A.M.; Girilal, M.; Mahdy, S.A.; Somsundar, S.S.; Venkatesan, R.; Kalaichelvan, P.T. Vancomycin bound biogenic gold nanoparticles: A different perspective for development of anti VRSA agents. Process Biochem. 2011, 46, 636-641. [CrossRef]
154. Ahangari, A.; Salouti, M.; Heidari, Z.; Kazemizadeh, A.R.; Safari, A.A. Development of gentamicin-gold nanospheres for antimicrobial drug delivery to Staphylococcal infected foci. Drug Deliv. 2013, 20, 34-39. [CrossRef] [PubMed]
155. Roshmi, T.; Soumya, K.R.; Jyothis, M.; Radhakrishnan, E.K. Effect of biofabricated gold nanoparticle-based antibiotic conjugates on minimum inhibitory concentration of bacterial isolates of clinical origin. Gold Bull. 2015, 48, 63-71. [CrossRef]
156. Dasari, T.S.; Zhang, Y.; Yu, H. Antibacterial Activity and Cytotoxicity of Gold (I) and (III) Ions and Gold Nanoparticles. Biochem. Pharmacol. 2015, 4. [CrossRef] [PubMed]
157. Kwak, K.; Kim, C. Viscosity and thermal conductivity of copper oxide nanofluid dispersed in ethylene glycol. Korea Aust. Rheol. J. 2005, 17, 35-40.
158. Phiwdang, K.; Suphankij, S.; Mekprasart, W.; Pecharapa, W. Synthesis of CuO nanoparticles by precipitation method using different precursors. Energy Procedia 2013, 34, 740-745. [CrossRef]
159. Sastry, A.B.S.; Aamanchi, R.K.; Prasad, C.S.R.L.; Murty, B.S. Large-scale green synthesis of Cu nanoparticles. Environ. Chem. Lett. 2013, 11, 183-187. [CrossRef]
160. Pramanik, A.; Laha, D.; Bhattacharya, D.; Pramanik, P.; Karmakar, P. A novel study of antibacterial activity of copper iodide nanoparticle mediated by DNA and membrane damage. Colloids Surf. B 2012, 96, 50-55. [CrossRef] [PubMed]
161. Weitz, I.S.; Maoz, M.; Panitz, D.; Eichler, S.; Segal, E. Combination of CuO nanoparticles and fluconazole: Preparation, characterization, and antifungal activity against Candida albicans. J. Nanopart. Res. 2015. [CrossRef]
162. Naika, H.R.; Lingaraju, K.; Manjunath, K.; Kumar, D.; Nagaraju, G.; Suresh, D.; Nagabhushana, H. Green synthesis of CuO nanoparticles using Gloriosa superba L. extract and their antibacterial activity. J. Taibah Univ. Sci. 2015, 9, 7-12. [CrossRef]
163. Khashan, K.S.; Sulaiman, G.M.; Abdulameer, F.A. Synthesis and Antibacterial Activity of CuO Nanoparticles Suspension Induced by Laser Ablation in Liquid. Arab. J. Sci. Eng. 2016, 41, 301-310. [CrossRef]
164. Martínez Flores, E.; Negrete, J.; Torres Villaseñor, G. Structure and properties of Zn-Al-Cu alloy reinforced with alumina particles. Mater. Des. 2003, 24, 281-286. [CrossRef]
165. Ghorbani, H.R. A review of methods for synthesis of Al nanoparticles. Orient. J. Chem. 2014, 30, 1941-1949. [CrossRef]
166. Mukherjee, A.; Mohammed Sadiq, I.; Prathna, T.C.; Chandrasekaran, N. Antimicrobial activity of aluminium oxide nanoparticles for potential clinical applications. Sci. Microb. Pathog. Commun. Curr. Res. Technol. Adv. 2011, 1, 245-251.
167. Balasubramanyam, A.; Sailaja, N.; Mahboob, M.; Rahman, M.F.; Hussain, S.M.; Grover, P. In vitro mutagenicity assessment ofaluminium oxide nanomaterials using the Salmonella/microsome assay. Toxicol. In Vitro 2010, 24, 1871-1876. [CrossRef] [PubMed]
168. 3 nanoparticles with Escherichia coli and their cell envelope biomolecules. J. Appl. Microbiol. 2014, 116, 772-783. [CrossRef] [PubMed]
169. Claudio, C.R.; Chellam, S. Bismuth nanoparticles: Antimicrobials of broad-spectrum, low cost and safety. In Nanomedicine; Seifalian, A., de Mel, A., Kalaskar, D.M., Eds.; One Central Press: Manchester, UK, 2015; pp. 430-437.
170. Badireddy, A.R.; Hernandez-Delgadillo, R.; Sanchez-Najera, R.I.; Chellam, S.; Cabral-Romero, C. Synthesis and characterization of lipophilic bismuth dimercaptopropanol nanoparticles and their effects on oral microorganisms growth and biofilm formation. J. Nanopart. Res. 2014, 16. [CrossRef]
171. Hernandez-Delgadillo, R.; Velasco-Arias, D.; Diaz, D.; Arevalo-Niño, K.; Garza-Enriquez, M.; de la Garza-Ramos, M.A.; Cabral-Romero, C. Zerovalent bismuth nanoparticles inhibit Streptococcus mutans growth and formation of biofilm. Int. J. Nanomed. 2012, 7, 2109-2113.
172. Hernandez-Delgadillo, R.; Velasco-Arias, D.; Martinez-Sanmiguel, J.J.; Diaz, D.; Zumeta-Dube, I.; Arevalo-Niño, K.; Cabral-Romero, C. Bismuth oxide aqueous colloidal nanoparticles inhibit Candida albicans growth and biofilm formation. Int. J. Nanomed. 2013, 8, 1645-1652.
173. Ageitos, J.M.; Chuah, J.A.; Numata, K. Design Considerations for Properties of Nanocarriers on Disposition and Efficiency of Drug and Gene Delivery. In Nanomedicines: Design, Delivery and Detection; Braddock, M., Ed.; Royal Society of Chemistry: London, UK, 2016. [CrossRef]
174. Buzea, C.; Pacheco, I.I.; Robbie, K. Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases 2007, 2, 17-71. [CrossRef]
175. Pacurar, M.; Qian, Y.; Fu, W.; Schwegler-Berry, D.; Ding, M.; Castranova, V.; Guo, N.L. Cell permeability, migration, and reactive oxygen species induced by multiwalled carbon nanotubes in human microvascular endothelial cells. J. Toxicol. Environ. Health 2012, 75, 129-147. [CrossRef] [PubMed]
176. Manke, A.; Wang, L.; Rojanasakul, Y. Mechanisms of nanoparticle-induced oxidative stress and toxicity. Biomed. Res. Int. 2013, 2013. [CrossRef] [PubMed]
177. Bellucci, S. Nanoparticles and Nanodevices in Biological Applications, Lecture Notes in Nanoscale Science and Technology; Springer-Verlag: Berlin/Heidelberg, Germany, 2009; Volume 1, pp. 47-67.
178. Deryabin, D.G.; Davydova, O.K.; Yankina, Z.Z.; Vasilchenko, A.S.; Miroshnikov, S.A.; Kornev, A.B.; Ivanchikhina, A.V.; Troshin, P.A. The activity of [60] fullerene derivatives bearing amine and carboxylic solubilizing groups against Escherichia coli: A comparative study. J. Nanomater. 2014, 2014. [CrossRef]
179. Arias, L.R.; Yang, L. Inactivation of bacterial pathogens by carbon nanotubes in suspensions. Langmuir 2009, 25, 3003-3012. [CrossRef] [PubMed]
180. Cataldo, F.; da Ros, T. Medicinal Chemistry and Pharmacological Potential of Fullerenes and Carbon Nanotubes; Springer: Dordrecht, The Netherlands, 2008; Volume 1, pp. 23-50.
181. Nakamura, S.; Mashino, T. Biological Activities of Water-Soluble Fullerene Derivatives; IOP Publishing: Philadelphia, PA, USA, 2009; Volume 159.
182. Akhavan, O.; Ghaderi, E. Toxicity of graphene and graphene oxide nanowalls against bacteria. ACS Nano 2010, 4, 5731-5736. [CrossRef] [PubMed]
183. Daima, H.K.; Bansal, V. Influence of Physicochemical Properties of Nanomaterials on Their Antibacterial Applications. In Nanotechnology in Diagnosis, Treatment and Prophylaxis of Infectious Diseases; Rai, M., Kon, K., Eds.; Academic Press/Elsevier: Boston, MA, USA, 2015. [CrossRef]
184. Kang, S.; Pinault, M.; Pfefferle, L.D.; Elimelech, M. Single-walled carbon nanotubes exhibit strong antimicrobial activity. Langmuir 2007, 23, 8670-8673. [CrossRef] [PubMed]
185. Vecitis, C.D.; Zodrow, K.R.; Kang, S.; Elimelech, M. Electronic-structure-dependent bacterial cytotoxicity of single-walled carbon nanotubes. ACS Nano 2010, 4, 5471-5479. [CrossRef] [PubMed]
186. Beyth, N.; Houri-Haddad, Y.; Domb, A.; Khan, W.; Hazan, R. Alternative antimicrobial approach: Nano-antimicrobial materials. Evid. Based Complement. Altern. Med. 2015, 2015. [CrossRef] [PubMed]
187. Kenawy, E.R.; Worley, S.D.; Broughton, R. The chemistry and applications of antimicrobial polymers: A state-of-the-art review. Biomacromolecules 2007, 8, 1359-1384. [CrossRef] [PubMed]
188. Zhou, C.; Qi, X.; Li, P.; Chen, W.N.; Mouad, L.; Chang, M.W.; Leong, S.S.J.; Chan-Park, M.B. High potency and broad-spectrum antimicrobial peptides synthesized via ring-opening polymerization of α-aminoacid-N-carboxyanhydrides. Biomacromolecules 2010, 11, 60-67. [CrossRef] [PubMed]
189. Xue, Y.; Xiao, H.; Zhang, Y. Antimicrobial Polymeric Materials with Quaternary Ammonium and Phosphonium Salts. Int. J. Mol. Sci. 2015, 16, 3626-3655. [CrossRef] [PubMed]
190. Wan, W.; Yeow, J.T. Antibacterial properties of poly (quaternary ammonium) modified gold and titanium dioxide nanoparticles. J. Nanosci. Nnotechnol. 2012, 12, 4601-4606. [CrossRef]
191. Song, J.; Kong, H.; Jang, J. Bacterial adhesion inhibition of the quaternary ammonium functionalized silica nanoparticles. Coll. Surf. B 2011, 82, 651-656. [CrossRef] [PubMed]
192. Yudovin-Farber, I.; Golenser, J.; Beyth, N.; Weiss, E.I.; Domb, A.J. Quaternary ammonium polyethyleneimine: Antibacterial activity. J. Nanomater. 2010, 2010. [CrossRef]
193. Zhang, H.; Wang, D.; Butler, R.; Campbell, N.L.; Long, J.; Tan, B.; Duncalf, D.J.; Foster, A.J.; Hopkinson, A.; Taylor, D.; et al. Formation and enhanced biocidal activity of water-dispersable organic nanoparticles. Nat. Nanotechnol. 2008, 3, 506-511. [CrossRef] [PubMed]
194. Sauvet, G.; Fortuniak, W.; Kazmierski, K.; Chojnowski, J. Amphiphilic block and statistical siloxane copolymers with antimicrobial activity. J. Polym. Sci. Part A Polym. Chem. 2003, 41, 2939-2948. [CrossRef]
195. Cheung, R.C.F.; Ng, T.B.; Wong, J.H.; Chan, W.Y. Chitosan: An update on potential biomedical and pharmaceutical applications. Mar. Drugs. 2015, 13, 5156-5186. [CrossRef] [PubMed]
196. Yien, L.; Zin, N.M.; Sarwar, A.; Katas, H. Antifungal activity of chitosan nanoparticles and correlation with their physical properties. Int. J. Biomater. 2012, 2012. [CrossRef]
197. Khandelwal, N.; Kaur, G.; Kumara, N.; Tiwari, A. Application of silver nanoparticles in viral inhibition: A new hope for antivirals. Dig. J. Nanomater. Biostruct. 2014, 9, 175-186.
198. Sun, R.W.; Chen, R.; Chung, N.P.; Ho, C.M.; Lin, C.L.; Che, C.M. Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells. Chem. Commun. 2005, 40, 5059-5061.
199. Lara, H.H.; Ayala-Nuñez, N.V.; Ixtepan-Turrent, L.; Rodriguez-Padilla, C. Mode of antiviral action of silver nanoparticles against HIV-1. J. Nanobiotechnol. 2010, 8. [CrossRef] [PubMed]
200. Lara, H.H.; Ixtepan-Turrent, L.; Garza-Treviño, E.N.; Rodriguez-Padilla, C. PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture. J. Nanobiotechnol. 2010, 8, 15-25. [CrossRef] [PubMed]
201. Lu, L.; Sun, R.W.; Chen, R.; Hui, C.K.; Ho, C.M.; Luk, J.M.; Lau, G.K.; Che, C.M. Nanoparticles inhibit hepatitis B virus replication. Antivir. Ther. 2008, 13, 253-262. [PubMed]
202. Mehrbod, P.; Motamed, N.; Tabatabaian, M.; Estyar, R.S.; Amini, E.; Shahidi, M.; Kheiri, M.T. In vitro antiviral effect of nanosilver on Influenza virus. DARU J. Pharm. Sci. 2009, 17, 88-93.
203. Xiang, D.X.; Chen, Q.; Pang, L.; Zheng, C.L. Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro. J. Virol. Methods 2011, 78, 137-142. [CrossRef] [PubMed]
204. Papp, I.; Sieben, C.; Ludwig, K.; Roskamp, M.; Böttcher, C.; Schlecht, S.; Herrmann, A.; Haag, R. Inhibition of Influenza virus infection by multivalent sialic-acid-functionalized gold nanoparticles. Small 2010, 6, 2900-2906. [CrossRef] [PubMed]
205. Speshock, J.L.; Murdock, R.C.; Braydich-Stolle, L.K.; Schrand, A.M.; Hussain, S.M. Interaction of silver nanoparticles with Tacaribe virus. J. Nanobiotechnol. 2010, 8. [CrossRef] [PubMed]
206. Rogers, J.V.; Parkinson, C.V.; Choi, Y.W.; Speshock, J.L.; Hussain, S.M. A preliminaryassessment of silver nanoparticles inhibition of Monkeypox virus plaque formation. Nanoscale Res. Lett. 2008, 3, 129-133.
207. Sun, L.; Singh, A.K.; Vig, K.; Pillai, S.; Shreekumar, R.; Singh, S.R. Silver nanoparticles inhibit replication of Respiratory Sincitial virus. J. Biomed. Biotechnol. 2008, 4, 149-158.
208. Baram-Pinto, D.; Shukla, S.; Perkas, N.; Gedanken, A.; Sarid, R. Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate. Bioconjug. Chem. 2009, 20, 1497-1502. [CrossRef] [PubMed]
209. Baram-Pinto, D.; Shukla, S.; Gedanken, A.; Sarid, R. Inhibition of HSV-1 attachment, entry, and cell-to-cell spread by functionalized multivalent gold nanoparticles. Small 2010, 6, 1044-1050. [CrossRef] [PubMed]
210. Mori, Y.; Ono, T.; Miyahira, Y.; Nguyen, V.Q.; Matsui, T.; Ishihara, M. Antiviral activity of silver nanoparticle/chitosan composites against H1N1 influenza A virus. Nanoscale Res. Lett. 2013, 8. [CrossRef] [PubMed]
211. Vijayakumar, S.; Ganesan, S. Gold nanoparticles as an HIV entry inhibitor. Curr. HIV Res. 2012, 10, 643-646. [CrossRef] [PubMed]
212. Broglie, J.J.; Alston, B.; Yang, C.; Ma, L.; Adcock, A.F.; Chen, W.; Yang, L. Antiviral Activity of Gold/Copper Sulfide Core/Shell Nanoparticles against Human Norovirus Virus-Like Particles. PLoS ONE 2015. [CrossRef] [PubMed]
213. Manuel, C.S.; Moore, M.D.; Jaykus, L.A. Destruction of the Capsid and Genome of GII.4 Human Norovirus Occurs during Exposure to Metal Alloys Containing Copper. Appl. Environ. Microbiol. 2015, 81, 4940-4946. [CrossRef] [PubMed]
214. Shionoiri, N.; Sato, T.; Fujimori, Y.; Nakayama, T.; Nemoto, M.; Matsunaga, T.; Tanaka, T. Investigation of the antiviral properties of copper iodide nanoparticles against feline calicivirus. J. Biosci. Bioeng. 2012, 113, 580-586. [CrossRef] [PubMed]
215. Amirkhanov, R.N.; Mazurkova, N.A.; Amirkhanov, N.V.; Zarytova, V.F. Composites of peptide nucleic acids with titanium dioxide nanoparticles. IV. Antiviral activity of nanocomposites containing DNA/PNA duplexes. Russ. J. Bioorg. Chem. 2015, 41, 140-146. [CrossRef]
216. Williams, D.F. On the mechanisms of biocompatibility. Biomaterials 2008, 29, 2941-2953. [CrossRef] [PubMed]
217. Li, X.; Wang, L.; Fan, Y.; Feng, Q.; Cui, F.Z. Biocompatibility and toxicity of nanoparticles and nanotubes. J. Nanomater. 2012, 2012. [CrossRef]
218. Reddy, N.N.; Varaprasad, K.; Ravindra, S. Evaluation of blood compatibility and drug release studies of gelatin based magnetic hydrogel nanocomposites. Colloids Surfaces A 2011, 385, 20-27. [CrossRef]
219. Li, P.W.; Kuo, T.H.; Chang, J.H.; Yeh, J.M.; Chan, W.H. Induction of cytotoxicity and apoptosis in mouse blastocysts by silver nanoparticles. Toxicol. Lett. 2010, 197, 82-87. [CrossRef] [PubMed]
220. Hadrup, N.; Lam, H.R. Oral toxicity of silver ions, silver nanoparticles and colloidal silver-A review. Regul. Toxicol. Pharmacol. 2014, 68. [CrossRef] [PubMed]
221. Hadrup, N.; Loeschner, K.; Mortensen, A. The similar neurotoxic effects of nanoparticulate and ionic silver in vivo and in vitro. Neurotoxicology 2012, 33, 416-423. [CrossRef] [PubMed]
222. Rim, K.T.; Song, S.W.; Kim, H.Y. Oxidative DNA damage from nanoparticle exposure and its application to workers' health: A literature review. Saf. Health Work 2013, 4, 177-186. [CrossRef] [PubMed]
223. De Jong, W.H.; Van Der Ven, L.T.; Sleijffers, A.; Park, M.V.; Jansen, E.H.; Van Loveren, H.; Vandebriel, R.J. Systemic and immunotoxicity of silver nanoparticles in an intravenous 28 days repeated dose toxicity study in rats. Biomaterials 2013, 34, 8333-8343. [CrossRef] [PubMed]
224. Gautam, A.; van Veggel, F.C.J.M. Synthesis of nanoparticles, their biocompatibility, and toxicity behavior for biomedical applications. J. Mater. Chem. B 2013, 1, 5186-5200. [CrossRef]
225. Flower, N.A.; Brabu, B.; Revathy, M.; Gopalakrishnan, C.; Raja, S.V.; Murugan, S.S.; Kumaravel, T.S. Characterization of synthesized silver nanoparticles and assessment of its genotoxicity potentials using the alkaline comet assay. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2012, 742, 61-65. [CrossRef] [PubMed]
226. Kim, J.S.; Sung, J.H.; Ji, J.H.; Song, K.S.; Lee, J.H.; Kang, C.S.; Yu, I.J. In vivo genotoxicity of silver nanoparticles after 90-day silver nanoparticle inhalation exposure. Saf. Health Work 2011, 2, 34-38. [CrossRef]
227. Kim, Y.S.; Kim, J.S.; Cho, H.S.; Rha, D.S.; Kim, J.M.; Park, J.D.; Choi, B.S.; Lim, R.; Chang, H.K.; Chung, Y.H.; et al. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 2008, 20, 575-583. [CrossRef] [PubMed]
228. Sung, J.H.; Ji, J.H.; Song, K.S.; Lee, J.H.; Choi, K.H.; Lee, S.H.; Yu, I.J. Acute inhalation toxicity of silver nanoparticles. Toxicol. Ind. Health 2011, 27, 149-154. [CrossRef] [PubMed]
229. Munger, M.A.; Radwanski, P.; Hadlock, G.C.; Stoddard, G.; Shaaban, A.; Falconer, J.; Grainger, D.W.; Deering-Rice, C.E. In vivo human time-exposure study of orally dosed commercial silver nanoparticles. Nanomed. Nanotechnol. Biol. Med. 2014, 10. [CrossRef] [PubMed]
230. Espinosa-Cristobal, L.F.; Martinez-Castanon, G.A.; Loyola-Rodriguez, J.P.; Patino-Marin, N.; Reyes-Macias, J.F.; Vargas-Morales, J.M.; Ruiz, F. Toxicity, distribution, and accumulation of silver nanoparticles in Wistar rats. J. Nanopart. Res. 2013, 15. [CrossRef]
231. Travan, A.; Pelillo, C.; Donati, I.; Marsich, E.; Benincasa, M.; Scarpa, T.; Semeraro, S.; Turco, G.; Gennaro, R.; Paoletti, S. Non-cytotoxic silver nanoparticle-polysaccharide nanocomposites with antimicrobial activity. Biomacromolecules 2009, 10, 1429-1435. [CrossRef] [PubMed]
232. Cao, X.L.; Cheng, C.; Ma, Y.L.; Zhao, C.S. Preparation of silver nanoparticles with antimicrobial activities and the researches of their biocompatibilities. J. Mater. Sci. Mater. Med. 2010, 21, 2861-2868. [CrossRef] [PubMed]
233. Hashimoto, M.; Toshima, H.; Yonezawa, T.; Kawai, K.; Narushima, T.; Kaga, M.; Endo, K. Responses of raw264.7 macrophages to water-dispersible gold and silver nanoparticles stabilized by metal-carbon sigma-bonds. J. Biomed. Mater. Res. A 2013, 102, 1838-1849. [CrossRef] [PubMed]
234. Barnett, C.M.; Gueorguieva, M.; Lees, M.R.; McGarvey, D.J.; Hoskins, C. Physical stability, biocompatibility and potential use of hybrid iron oxide-gold nanoparticles as drug carriers. J. Nanopart. Res. 2013, 15. [CrossRef]
235. Gamucci, O.; Bertero, A.; Gagliardi, M.; Bardi, G. Biomedical Nanoparticles: Overview of Their Surface Immune-Compatibility. Coatings 2014, 4, 139-159. [CrossRef]
236. Fabian, E.; Landsiedel, R.; Ma-Hock, L.; Wiench, K.; Wohlleben, W.; van Ravenzwaay, B. Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. Arch. Toxicol. 2008, 82. [CrossRef] [PubMed]
237. Shi, Y.; Miller, M.L.; Di Pasqua, A.J. Biocompatibility of Mesoporous Silica Nanoparticles? Comm. Inorg. Chem. 2016, 36. [CrossRef]
238. 4) nanoparticles for their biocompatibility with murine breast cancer cells (4T1). Molecules 2016, 21. [CrossRef] [PubMed]
239. Tomitaka, A.; Jeun, M.; Bae, S.; Takemura, Y. Evaluation of magnetic and thermal properties of ferrite nanoparticles for biomedical applications. J. Magnet. 2011, 16, 164-168. [CrossRef]
240. Iavicoli, I.; Leso, V.; Fontana, L.; Bergamaschi, A. Toxicological effects of titanium dioxide nanoparticles: A review of in vitro mammalian studies. Eur. Rev. Med. Pharmacol. Sci. 2011, 15, 481-508. [PubMed]
241. Khanna, L.; Verma, N.K. Synthesis, characterization and in vitro cytotoxicity study of calcium ferrite nanoparticles. Mater. Sci. Semiconduct. Process. 2013, 16, 1842-1848. [CrossRef]
242. Sosnik, A.; Carcaboso, A.M.; Glisoni, R.J.; Moretton, M.A.; Chiappetta, D.A. New old challenges in tuberculosis: Potentially effective nanotechnologies in drug delivery. Adv. Drug Deliv. Rev. 2010, 62, 547-559. [CrossRef] [PubMed]
243. Sarfati, G.; Dvir, T.; Elkabets, M.; Apte, R.N.; Cohen, S. Targeting of polymeric nanoparticles to lung metastases by surface-attachment of YIGSR peptide from laminin. Biomaterials 2011, 32, 152-161. [CrossRef]
244. Naahidi, S.; Jafari, M.; Edalat, F.; Raymond, K.; Khademhosseini, A.; Chen, P. Biocompatibility of engineered nanoparticles for drug delivery. J. Control. Release 2013, 166, 182-194. [CrossRef] [PubMed]
245. Labhasetwar, V.; Song, C.; Levy, R.J. Nanoparticle drug delivery system for restenosis. Adv. Drug Deliv. Rev. 1997, 24, 63-85. [CrossRef]
246. Mahapatro, A.; Singh, D.K. Biodegradable nanoparticles are excellent vehicle for site directed in vivo delivery of drugs and vaccines. J. Nanobiotechnol. 2011, 9. [CrossRef] [PubMed]
247. Kumari, A.; Yadav, S.K.; Yadav, S.C. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf. B Biointerfaces 2010, 75. [CrossRef] [PubMed]
248. Carrasquillo, K.G.; Stanley, A.M.; Aponte-Carro, J.C.; de Jésus, P.; Costantino, H.R.; Bosques, C.J.; Griebenow, K. Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein. J. Control. Release 2001, 76, 199-208. [CrossRef]
249. Kim, D.; El-Shall, H.; Dennis, D.; Morey, T. Interaction of PLGA nanoparticles with human blood constituents. Colloids Surf. B Biointerfaces 2005, 40, 83-91. [CrossRef] [PubMed]
250. Leroux, J.C.; Allémann, E.; de Jaeghere, F.; Doelker, E.; Gurny, R. Biodegradable nanoparticles from sustained release formulations to improved site specific drug delivery. J. Control. Release 1996, 39, 339-350. [CrossRef]
251. Tobío, M.; Sánchez, A.; Vila, A.; Soriano, I.; Evora, C.; Vila-Jato, J.L.; Alonso, M.J. The role of PEG on the stability in digestive fluids and in vivo fate of PEGPLA nanoparticles following oral administration. Colloids Surf. B Biointerfaces 2000, 18, 315-323. [CrossRef]
252. Suri, S.S.; Fenniri, H.; Singh, B. Nanotechnology-based drug delivery systems. J. Occup. Med. Toxicol. 2007, 2. [CrossRef] [PubMed]
253. Nevozhay, D.; Kañska, U.; Budzyñska, R.; Boratyñski, J. Current status of research on conjugates and related drug delivery systems in the treatment of cancer and other diseases (Polish). Postepy Hig. Med. Dosw. 2007, 61, 350-360.
254. Wilczewska, A.Z.; Katarzyna Niemirowicz, K.; Markiewicz, K.H.; Car, H. Nanoparticles as drug delivery systems. Pharmacol. Rep. 2012, 64, 1020-1037. [CrossRef]
255. Steiniger, S.C.; Kreuter, J.; Khalansky, A.S.; Skidan, I.N.; Bobruskin, A.I.; Smirnova, Z.S.; Severin, S.E.; Uhl, R.; Kock, M.; Geiger, K.D.; et al. Chemotherapy of glioblastoma in rats using doxorubicinloaded nanoparticles. Int. J. Cancer 2004, 109, 759-767. [CrossRef] [PubMed]
256. Sumner, J.P.; Kopelman, R. Alexa Fluor 488 as an iron sensing molecule and its application in PEBBLE nanosensors. Analyst 2005, 130, 528-533. [CrossRef] [PubMed]
257. Shinde, R.R.; Bachmann, M.H.; Wang, Q.; Kasper, R.; Contag, C.H. PEGPLA/PLGA Nanoparticles for in vivo RNAi Delivery; NSTI Nano Tech.: Santa Clara, CA, USA, 2007.
258. Tan, W.B.; Jiang, S.; Zhang, Y. Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference. Biomaterials 2007, 28, 1565-1571. [CrossRef] [PubMed]
259. Zhang, Y.; Sun, C.; Kohler, N.; Zhang, M. Self-Assembled Coatings on Individual Monodisperse Magnetite Nanoparticles for Efficient Intracellular Uptake. Biomed. Microdev. 2004, 6, 33-40. [CrossRef]
260. Fakruddin, M.; Hossain, Z.; Afroz, H. Prospects and applications of nanobiotechnology: A medical perspective. J. Nanobiotechnol. 2012, 10. [CrossRef] [PubMed]
261. Choi, J.; Wang, N.S. Nanoparticles in Biomedical Applications and Their Safety Concerns. In Biomedical Engineering-From Theory to Applications; Fazel-Rezai, R., Ed.; InTech Publisher: Rijeka, Croatia, 2011.
262. Gwinn, M.R.; Vallyathan, V. Nanoparticles: Health effects-Pros and Cons. Environ. Health Perspect. 2006, 114, 1818-1825. [CrossRef] [PubMed]